# Board Presentation * **Definition:** A formal presentation delivered to the board of directors or governing body of a healthcare organization, typically outlining strategic initiatives, performance metrics, financial status, and key operational updates, aimed at facilitating informed decision-making and governance. * **Taxonomy:** CTO Topics / Board Presentation ## News * Selected news on the topic of **Board Presentation**, for healthcare technology leaders * 870 news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/19/2025 | [**Jump Comes Out Of Stealth With A Solution To The B2B SaaS Integration Crisis**](https://venturebeat.com/business/jump-comes-out-of-stealth-with-a-solution-to-the-b2b-saas-integration-crisis/) | [[VentureBeat]] | | 4/22/2025 | [**Mouser Electronics New Product Insider: Over 8,000 New Parts Added in First Quarter of 2025**](https://www.prnewswire.com/apac/news-releases/mouser-electronics-new-product-insider-over-8-000-new-parts-added-in-first-quarter-of-2025--302434159.html) | [[PR Newswire]] | | 4/7/2025 | [**Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy**](https://www.prnewswire.com/news-releases/gift-of-life-biologics-and-cellex-cell-professionals-gmbh-celebrate-successful-partnership-to-deliver-high-quality-starting-materials-for-final-drug-product-manufacturing-in-cell-and-gene-therapy-302408010.html) | [[PR Newswire]] | | 4/7/2025 | [**Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy**](https://www.prnewswire.com/news-releases/gift-of-life-biologics-and-cellex-cell-professionals-gmbh-celebrate-successful-partnership-to-deliver-high-quality-starting-materials-for-final-drug-product-manufacturing-in-cell-and-gene-therapy-302408090.html) | [[PR Newswire]] | | 4/6/2025 | [**Dachser grows through acquisitions - PR Newswire**](https://www.prnewswire.com/apac/news-releases/dachser-grows-through-acquisitions-302421570.html) | [[PR Newswire]] | | 3/28/2025 | [**Cutting-Edge PK and Immunogenicity Strategies for Next-Generation ADCs, ARCs, and Conjugated Biotherapeutics, Upcoming Webinar Hosted by Xtalks**](https://www.prweb.com/releases/cutting-edge-pk-and-immunogenicity-strategies-for-next-generation-adcs-arcs-and-conjugated-biotherapeutics-upcoming-webinar-hosted-by-xtalks-302414282.html) | [[PRWeb]] | | 3/20/2025 | [**Digital Health Market Size, Share & Trends Analysis Report by Technology, Component ... - LinkedIn**](https://www.linkedin.com/pulse/digital-health-market-size-share-trends-analysis-1jwte) | [[Linkedin]] | | 3/7/2025 | [**Why Private Equity Healthcare Dealmaking Is Expected to Rise in 2025**](https://www.healthleadersmedia.com/ceo/why-private-equity-healthcare-dealmaking-expected-rise-2025) | [[HealthLeaders Media]] | | 11/14/2024 | [**Generative AI impact: Real data + unfiltered perspectives**](https://www.beckershospitalreview.com/innovation/generative-ai-impact-real-data-unfiltered-perspectives.html) | [[Beckers Hospital Review]] | | 11/12/2024 | [**Promega and QuantumCyte Sign Co-Marketing Agreement, Present Joint Poster at Association for Molecular Pathology (AMP) 2024 Meeting**](http://www.businesswire.com/news/home/20241111895238/en/Promega-and-QuantumCyte-Sign-Co-Marketing-Agreement-Present-Joint-Poster-at-Association-for-Molecular-Pathology-AMP-2024-Meeting/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/7/2024 | [**Behavioral Health Tech Spotlights the Next Wave of MH/SUD Innovation, Leadership and Progress**](https://www.healthleadersmedia.com/payer/behavioral-health-tech-spotlights-next-wave-mhsud-innovation-leadership-and-progress) | [[HealthLeaders Media]] | | 10/31/2024 | [**HMNC Brain Health to Present Advances in Precision Psychiatry and Psychedelics at CNS Summit 2024 in Boston**](https://www.globenewswire.com/news-release/2024/10/31/2972692/0/en/HMNC-Brain-Health-to-Present-Advances-in-Precision-Psychiatry-and-Psychedelics-at-CNS-Summit-2024-in-Boston.html) | [[Globe Newswire]] | | 9/18/2024 | [**Coalition, Politico host event on the role of telehealth, other technologies in advancing patient care**](https://www.aha.org/news/headline/2024-09-18-coalition-politico-host-event-role-telehealth-other-technologies-advancing-patient-care) | aha.org | | 9/18/2024 | [**Considerations For AI Use In Biomanufacturing - Bioprocess Online**](https://www.bioprocessonline.com/doc/considerations-for-ai-use-in-biomanufacturing-0001) | bioprocessonline.com | | 9/3/2024 | [**Interest Group Sessions (NAM Annual Meeting) - National Academy of Medicine**](https://nam.edu/event/interest-group-sessions-nam-annual-meeting-2024/) | nam.edu | | 8/27/2024 | [**New Maryland test scores for English, math show little change across schools - Yahoo**](https://www.yahoo.com/news/maryland-test-scores-english-math-143200675.html) | [[Yahoo]] | | 8/26/2024 | [**4 Days Away! Cyber, IT, and AI! Celebrating the Distinguished Career of Diane Frasier ...**](https://myemail-api.constantcontact.com/4-Days-Away--Cyber--IT--and-AI--Celebrating-the-Distinguished-Career-of-Diane-Frasier--Former-NIH-Contracting-Leader--.html?soid=1011284281035&aid=DAYZrtNtmGo) | myemail-api.constantcontact.com | | 8/12/2024 | [**QARA Professionals Question a Future with Cybersecurity Issues, US Litigation, and the EU AI Act**](https://www.biospace.com/policy/qara-professionals-question-a-future-with-cybersecurity-issues-us-litigation-and-the-eu-ai-act) | biospace.com | | 8/2/2024 | [**Pharma Industry Needs Precise FDA Guidelines for AI, ML, and RPA Validation : Experts**](https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/pharma-industry-needs-precise-fda-guidelines-for-ai-ml-and-rpa-validation-experts/112244563) | health.economictimes.indiatimes.com | | 7/31/2024 | [**How Are Health Systems and Health Tech Addressing Cybersecurity? A Timely Panel ...**](https://medcitynews.com/2024/07/how-are-health-systems-and-health-tech-addressing-cybersecurity-a-timely-panel-discussion-at-invest-digital-health/) | [[MedCity News]] | | 7/8/2024 | [**Egnyte Launches Generative AI-based Copilot to Speed up Knowledge Work and Unlock ...**](https://finance.yahoo.com/news/egnyte-launches-generative-ai-based-150000099.html) | [[Yahoo Finance]] | | 7/2/2024 | [**Celebrating Excellence and Innovation in the Global Business Community**](https://theprint.in/ani-press-releases/celebrating-excellence-and-innovation-in-the-global-business-community/2158374/) | theprint.in | | 6/27/2024 | [**Center for Health and Business Hosts International Summit on AI in the Life Sciences Industry**](https://www.bentley.edu/news/center-health-and-business-hosts-international-summit-ai-life-sciences-industry) | bentley.edu | | 6/26/2024 | [**Generative AI in Healthcare: Advancing the Skills of Medical Professionals - Eventbrite**](https://www.eventbrite.com/e/generative-ai-in-healthcare-advancing-the-skills-of-medical-professionals-tickets-934698025957) | eventbrite.com | | 3/12/2024 | [**GenAI needs guardrails to flourish in healthcare**](https://www.healthcarefinancenews.com/news/genai-needs-guardrails-flourish-healthcare) | [[Healthcare Finance]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Gan & Lee Pharmaceuticals**: A pharmaceutical company presenting investigational products at the American Diabetes Association's Scientific Sessions. - **Bright Minds Biosciences**: A company focused on developing innovative treatments for neurological and psychiatric disorders. - **4D Molecular Therapeutics**: A clinical-stage company focusing on genetic medicines, presenting at the North American Cystic Fibrosis Conference. - **Caribou Biosciences**: A biotechnology company presenting preclinical data on CAR-T cell therapy for lupus nephritis. - **Median Technologies**: A company presenting results of a lung cancer screening device at the ESMO Congress. - **Robert Maguire**: Panelist discussing the ethical implications of AI in healthcare. - **Scilex Holding Company**: A company focused on non-opioid pain management products, presenting at the American Headache Society meeting. - **IDEAYA Biosciences**: A company focusing on precision medicine in oncology, presenting Phase 1 results at the EORTC-NCI-AACR Symposium. - **Shez Partovi**: Chief Innovation & Strategy Officer at Philips, discussing generative AI in healthcare. - **Micky Tripathi**: Official from the Department of Health and Human Services discussing AI regulation. - **BostonGene**: A company utilizing AI-driven molecular profiling to enhance precision medicine in cancer care. - **Danielle Blanch Hartigan**: Expert in AI applications in healthcare, emphasizing the need for human oversight. - **23andMe**: A biotechnology company presenting clinical data on monoclonal antibodies at the ESMO Congress. - **Amplo Biotechnology**: Specializes in genetic medicines targeting rare and super-rare neuromuscular diseases. - **Opna Bio**: A clinical-stage biopharmaceutical company developing therapies for oncology, including OPN-2853 and OPN-6602. - **Mallinckrodt plc**: A global specialty pharmaceutical company focused on pain management and critical care. - **ENT Partners, LLC**: A physician practice management company specializing in the Ear, Nose, Throat, Facial Plastics & Sleep industry, recently expanded its presence in Baltimore through acquisitions. - **Dr. Ramesh Jain**: Leading figure in AI and healthcare, focusing on data-driven approaches. - **Resolution Therapeutics Limited**: Focused on developing macrophage therapies for inflammatory and fibrotic diseases. - **Data.world**: A company enhancing national biosurveillance capabilities through advanced data analytics. ### Partnerships and Collaborations - **HMNC Brain Health**: Engages in discussions on the future of psychedelics in mental health care at the CNS Summit. - **Conference Forum and Sites Summit**: A collaboration to enhance patient enrollment processes in clinical trials. - **Deloitte**: Sara Siegel moderated discussions on generative AI in healthcare. - **Global Capability Centers (GCCs)**: Facilitate collaboration between global and local content creation teams to enhance medical content delivery. - **Ichnos Glenmark Innovation**: A partnership focused on accelerating drug discovery in cancer treatment. - **Coalition to Strengthen America's Healthcare**: Hosted an event to explore innovations in telehealth and AI. - **University of Chicago**: Provided survey results indicating improved patient and provider satisfaction through the use of ambient clinical documentation technology. - **Coalition for Health AI**: A collaborative effort formed to create responsible usage guidelines for AI in healthcare. - **Microsoft**: Collaborated with Carilion Clinic on a pilot program for patient inquiries. - **4D Molecular Therapeutics**: Pursues gene editing programs through partnerships. - **Lineage Cell Therapeutics and Eterna Therapeutics**: Collaboration to develop allogeneic cell therapies for unmet medical needs. - **Gift of Life Biologics and Cellex Cell Professionals GmbH**: A partnership aimed at providing high-quality starting materials for cell and gene therapy manufacturing. - **Promega and QuantumCyte**: Entered a strategic joint marketing agreement to enhance workflow solutions for clinical laboratories. - **Egnyte**: Collaborates with various platforms for seamless integration of Egnyte Copilot into existing workflows. ### Innovations, Trends, and Initiatives - **AI Pavilion at HLTH Conference**: Showcased offerings from major companies, highlighting the role of AI in healthcare. - **Gan & Lee Pharmaceuticals**: Innovations in diabetes management with investigational GLP-1 analogs and insulin therapies. - **Generative AI in Healthcare**: Panel discussions exploring AI's role in enhancing medical professionals' skills. - **AI Assurance Laboratories**: Discussion on establishing a national network for AI regulation. - **Median Technologies**: Develops a SaMD lung cancer screening device, showcasing positive verification study results. - **Egnyte Copilot**: An AI-driven assistant that enhances content collaboration with features like document summarization and multimedia transcription. - **MCPAP for Moms**: A program aimed at improving maternal mental health care through training and resources for healthcare providers. - **Generative AI Applications**: Panel discussions emphasize the potential of Generative AI to reduce physician burnout and improve efficiency in healthcare. - **Telehealth Scrutiny**: Increased scrutiny over telehealth practices related to GLP-1 medications. - **AI-powered Solutions**: Increasing adoption in patient monitoring and personalized care within the digital health industry. - **AI in Healthcare**: Discussions at various conferences highlight the transformative potential of AI in improving diagnostics and personalized treatment plans. - **3D Printing**: Highlighted as a significant technology in personalized medical solutions and tooling, impacting the future of healthcare delivery. - **Real-World Evidence (RWE)**: Flatiron Health emphasizes the importance of RWE in healthcare decision-making and market access. - **AI Literacy**: Future Talent Council emphasized the need for AI literacy in the workforce. - **Generative AI**: Increasingly utilized in healthcare, particularly in ambient clinical documentation to alleviate clinician burnout and improve patient experience. - **Scilex**: Focuses on non-opioid therapies for pain management, addressing unmet medical needs. - **Investor Interest in AI**: Surge in venture capital interest in AI technologies within the healthcare sector. - **Digital Health Market Growth**: Projected to grow from USD 288.55 billion in 2024 to USD 946.04 billion by 2030, driven by healthcare IT advancements and remote patient monitoring. - **Ziftomenib in AML**: Kura Oncology's ziftomenib shows promise in treating high-risk AML, with ongoing clinical trials to evaluate its effectiveness. ### Challenges and Concerns - **Ethical Considerations**: Panelists stressed the importance of ethical decision-making in AI applications. - **Physician Shortage**: Raising questions about the effectiveness of Advanced Practice Providers (APPs) in addressing workforce challenges. - **AI Deployment Caution**: Health system executives express concerns regarding safety, efficacy, and privacy in AI deployment. - **Regulatory Scrutiny**: Intensified under the Biden administration, affecting private equity ownership in healthcare, but expected to diminish under the Trump administration. - **Provider Feedback**: Successful deployment of new technologies relies on vendor responsiveness to provider feedback during pilot phases. - **AI Adoption**: Egnyte Copilot addresses challenges in AI adoption by ensuring data privacy and requiring minimal user training. - **AI Implementation Risks**: Concerns about the ethical use of AI in healthcare, including data security and the potential for introducing new challenges. - **Cultural Differences**: The need for flexible global directives that accommodate regional cultural differences in healthcare communication. - **Telehealth Practices**: Concerns over the practices of telehealth companies regarding medication prescriptions. - **Disparities in Care**: Efforts to eliminate racial disparities in palliative care and ensure equitable access to services. - **Data Quality Issues**: Challenges in integrating AI technologies in the pharmaceutical sector. - **Maternal Mental Health Gaps**: Significant gaps in mental health services for pregnant and postpartum individuals, highlighting the need for better support systems. - **Regulatory Compliance**: Median Technologies emphasizes compliance with stringent standards in medical device development. - **Market Competition**: Companies like Scilex and 23andMe face competition in the rapidly evolving healthcare technology landscape. - **Trust in AI**: 77% of Americans express skepticism about corporate AI practices. - **Cybersecurity Risks**: Healthcare industry faces significant cybersecurity threats, necessitating risk management. - **Cybersecurity Threats**: Healthcare organizations face increasing cybersecurity threats, necessitating enhanced defenses against ransomware attacks. ## Related Topics [[Executive Presentation]]